How to Buy Tenet Healthcare Stock
Tenet Healthcare Corp
Tenet Healthcare is a medical care facility company located in Texas, United States, which is part of the Healthcare sector, and is traded under the ticker THC on the NYSE exchange.
Tenet Healthcare stock last closed at $164.37, down 0.71% from the previous day, and has increased 17.84% in one year. It has overperformed other stocks in the Medical Care Facilities industry by 0.28 percentage points. Tenet Healthcare stock is currently +49.67% from its 52-week low of $109.82, and -5.61% from its 52-week high of $174.14.
As of Jun 13, 2025, there are 92.89M THC shares outstanding. The market capitalization of THC is $15.27B. In the past 24 hours, 1.84M THC shares were traded.
How to Buy Tenet Healthcare Stock
Not sure how to invest in Tenet Healthcare stock? Here's how.
- Decide where to buy Tenet Healthcare stock: You need to pick a stock brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you figure out where to buy Tenet Healthcare stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Fund your investment account: Choose your method of payment and add your information.
- Research Tenet Healthcare stock: The Tenet Healthcare ticker symbol is THC. Is Tenet Healthcare stock a good investment? Should you buy shares of THC? How do THC's underlying business fundamentals look? Do top analysts think Tenet Healthcare is a good buy? Why has THC's stock price moved recently? (Hint: Our stock analysis website can help you decide if THC is a good stock to buy).
- Place your THC purchase: Decide if you will purchase THC shares at the current market price or use a limit order to purchase THC stock at a given price.
- Monitor your THC investment: Create a watchlist to keep tabs on your investment in Tenet Healthcare shares.
Step 1: Decide where to buy Tenet Healthcare stock
You will need an online brokerage account to access the NYSE market and buy THC stock.
Our recommended brokerage: eToro
Based on our experience, eToro is the best online stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world markets: From Technology to Real Estate, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've chosen the right brokerage, you'll need to fill out some personal details so you can invest in THC stock today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to start a new brokerage account.
- Submit your info by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you have filled out your info on the stocks app, your next step is to transfer the money for your investment:
Check out the tutorial below if you need help transferring funds into your new investment account.
Step 4: Research Tenet Healthcare stock
After you have figured out the best place to buy Tenet Healthcare stock, it's critical to evaluate their stock before you invest, so you truly understand the risk as well as the opportunity.
Tenet Healthcare quick stats
THC Fundamentals
WallStreetZen was created to help everyday investors do more accurate fundamental analysis.
You can view all of the due diligence checks on THC's stock page.
Is THC stock overvalued?
You can use many financial metrics, analyses, models, and charts to gauge THC's true value.
Using relative valuations measures:
- THC may be undervalued based on its P/E ratio of 10.7x, relative to Medical Care Facilities industry P/E ratio of 16.48x
- THC may be undervalued based on its P/B ratio of 3.65x, relative to Medical Care Facilities industry P/B ratio of 4.55x
- THC may be overvalued based on its PEG ratio of 62.53x
You can access additional valuation analysis on THC's stock here.
THC Financial Health
Signs that THC is financially healthy:
- There are more short-term assets than short-term liabilities on the THC balance sheet.
- Total THC debt is lower than 5 years ago, relative to shareholder equity.
Signs that THC is not financially healthy:
- THC profit margin has gone down from 12.5% to 7.1% in the past year.
- THC has a relatively high debt to equity ratio of 4.92.
- There are more long-term liabilities than short-term assets on the THC balance sheet.
- THC earnings of $2.84B is not sufficient to cover its interest payments.
- THC's operating cash flow of $2.28B allows it to safely service it's debt of $13.17B.
Is THC stock a Buy, Hold, or Sell, according to analysts?
Out of 13 Equities analysts who research THC, the consensus analyst rating on Tenet Healthcare is a Strong Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
Most Recent THC Analyst Ratings
Jamie Perse, a top 17% analyst from Goldman Sachs maintains THC with a hold rating and raises their THC price target from $134.00 to $154.00, on May 5, 2025.
Ben Hendrix, a top 23% analyst from RBC Capital maintains THC with a buy rating and raises their THC price target from $183.00 to $189.00, on Apr 30, 2025.
A.J. Rice, a top 11% analyst from UBS maintains THC with a strong buy rating and raises their THC price target from $217.00 to $230.00, on Apr 30, 2025.
UBS's A.J. Rice raised their price target on Tenet Healthcare (NYSE: THC) by 6% from $217 to $230 on 2025/04/30. The analyst maintained their Strong Buy rating on the stock.
Tenet Healthcare reported its Q1 2025 earnings.
Rice attributed their price target hike to the print revealing "labor efficiencies driving a fundamental outperformance, and a runway that remains outsized for the company's high-acuity ambulatory surgery center strategy.
Earnings Report
For Q1 2025, Tenet Healthcare reported:
- EPS of $4.36, which beat the Zacks Consensus Estimate of $3.11 and Q1 2024's $3.22.
- Revenue of $5.22B, which beat the Zacks Consensus Estimate by 1.64% but missed Q1 2024's $5.37B.
For FY 2025, management guided:
- EPS of $11.99 to $13.12.
- Revenue of $20.6B to $21B.
Chairman & CEO Saum Sutaria, M.D., commented: "We had an excellent start to the year driven by strong same-store revenue growth and operational discipline, resulting in earnings and cash flows well ahead of our expectations.
"We continue to expand access to high-quality specialty care as we effectively execute on our mission to deliver quality, compassionate care in the communities we serve."
Michael Ha, a bottom 8% analyst from Baird downgrades THC to a hold rating and lowers their THC price target from $153.00 to $137.00, on Apr 15, 2025.
Jason Cassorla, a bottom 9% analyst from Guggenheim initiates coverage on THC with a strong buy rating and announces their THC price target of $165.00, on Apr 9, 2025.
You can dig deeper into what analysts are saying on the Tenet Healthcare stock forecast page.
THC Trading Indicators
How are THC Revenues/Earnings doing?
Last year, THC earnings were $1.46B. In the last four year, THC's earnings have gone up by 41.51% per year. This was faster than the Medical Care Facilities industry average of 18.06%.
Last year, THC revenue was $20.53B. During the past 5 year, THC's revenue has increased by 2.16% per year. This was slower than the Medical Care Facilities industry average of 7.15%.
Dig into THC's earnings and revenue performance here.
What are THC executives and large shareholders up to?
In the past year, insiders at THC have sold more shares than they have bought.
Paola M. Arbour, EVP Chief Information Officer of THC, was the latest THC insider to sell. They sold $1,338,674.00 worth of THC shares on Jun 5, 2025.
Dig into more about who owns THC shares here.
Can I rely on THC as an income stream?
No, Tenet Healthcare doesn't provide an income stream by paying out dividends.
What others are saying about THC
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Place your THC purchase
There are two primary options:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are usually fine. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a particular price limit, place a limit order.
Hit the Open Trade button and eToro will place the order.
If you need more assistance investing in stocks on eToro, watch the how to video below:
Step 6: Monitor your THC investment
Now that you own some THC shares, you'll want to keep up with your investment.
Add THC to a watchlist to get notified of the latest news about your THC stock.
THC Feed
How to Buy Stock in Tenet Healthcare
To summarize, here are the 6 steps to buy Tenet Healthcare stock:
- Decide where to buy Tenet Healthcare stock
- Create a brokerage account
- Fund your investment account
- Research Tenet Healthcare stock
- Place your THC purchase
- Monitor your THC investment
If you need a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you want to keep tabs on your investment in Tenet Healthcare, create a watchlist on WallStreetZen today.
Other Stock Buying Guides You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.